Group One Trading’s Oramed Pharmaceuticals ORMP Stock Holding History

Group One Trading’s Portfolio ORMP Stock Details ORMP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$78.5K	Buy	23,100 +16,600	+255%	+$56.3K	﹤0.01%	4931
2025 Q4	$18.5K	Sell	6,500 -46,400	-88%	-$120K	﹤0.01%	6391
2025 Q3	$140K	Sell	52,900 -25,400	-32%	-$56.1K	﹤0.01%	5023
2025 Q2	$176K	Buy	78,300 +77,900	+19,475%	+$172K	﹤0.01%	4465
2025 Q1	$856	Sell	400 -400	-50%	-$923	﹤0.01%	7205
2024 Q4	$1.94K	Sell	800 -3,700	-82%	-$8.79K	﹤0.01%	6748
2024 Q3	$11K	Sell	4,500 -11,500	-72%	-$28K	﹤0.01%	5554
2024 Q2	$41.1K	Buy	16,000 +14,600	+1,043%	+$34.7K	﹤0.01%	4667
2024 Q1	$4.09K	Sell	1,400 -15,000	-91%	-$41.9K	﹤0.01%	6267
2023 Q4	$37.9K	Sell	16,400 -17,800	-52%	-$38K	﹤0.01%	5284
2023 Q3	$89.3K	Sell	34,200 -57,400	-63%	-$181K	﹤0.01%	4556
2023 Q2	$328K	Sell	91,600 -10,700	-10%	-$34.3K	﹤0.01%	3450
2023 Q1	$223K	Buy	102,300 +64,700	+172%	+$206K	﹤0.01%	3570
2022 Q4	$452K	Sell	37,600 -129,300	-77%	-$1.01M	﹤0.01%	3138
2022 Q3	$1.08M	Buy	166,900 +134,500	+415%	+$1.09M	﹤0.01%	2508
2022 Q2	$148K	Sell	32,400 -17,900	-36%	-$95.6K	﹤0.01%	4595
2022 Q1	$435K	Sell	50,300 -2,700	-5%	-$27.7K	﹤0.01%	3964
2021 Q4	$757K	Sell	53,000 -38,900	-42%	-$813K	﹤0.01%	3641
2021 Q3	$2.02M	Sell	91,900 -21,700	-19%	-$370K	﹤0.01%	2641
2021 Q2	$1.52M	Sell	113,600 -63,900	-36%	-$731K	﹤0.01%	2934
2021 Q1	$1.8M	Buy	177,500 +123,200	+227%	+$1.01M	﹤0.01%	2580
2020 Q4	$230K	Buy	+54,300	New	+$177K	﹤0.01%	3961
2020 Q3	–	Sell	-31,600	Closed	-$112K	–	6422
2020 Q2	$112K	Buy	31,600 +6,600	+26%	+$22.1K	﹤0.01%	3810
2020 Q1	$76K	Sell	25,000 -15,800	-39%	-$69.2K	﹤0.01%	3480
2019 Q4	$210K	Buy	+40,800	New	+$153K	﹤0.01%	3136
2019 Q1	–	Sell	-36,000	Closed	-$108K	–	5213
2018 Q4	$108K	Buy	+36,000	New	+$149K	﹤0.01%	3117
2018 Q1	–	Sell	-500	Closed	-$5K	–	5185
2017 Q4	$5K	Buy	+500	New	+$4.78K	﹤0.01%	4567
2016 Q4	–	Sell	-75,500	Closed	-$548K	–	4713
2016 Q3	$548K	Hold	75,500	–	–	0.01%	1751
2016 Q2	$630K	Buy	+75,500	New	+$643K	0.01%	1571
2015 Q3	–	Sell	-10,200	Closed	-$58K	–	5096
2015 Q2	$58K	Buy	+10,200	New	+$69.8K	﹤0.01%	3456
2014 Q4	–	Sell	-200	Closed	-$2K	–	5169
2014 Q3	$2K	Sell	200 -8,500	-98%	-$75.6K	﹤0.01%	4932
2014 Q2	$84K	Sell	8,700 -11,600	-57%	-$118K	﹤0.01%	3157
2014 Q1	$235K	Buy	+20,300	New	+$343K	﹤0.01%	2310

Other funds holding ORMP

BCM

BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return

Aquamarine Financial George Town $1.37B AUM

Mercer Global Advisors Denver, Colorado $67.6B AUM 18.3% 1-Year Est. Return

GIA

Gem Investment Advisors Teaneck, New Jersey $102M AUM

Murchinson Toronto, Ontario, Canada $791M AUM 68.08% 1-Year Est. Return

BFM

Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Rathbones Group Liverpool, United Kingdom $25B AUM 18.87% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Group One Trading's ORMP Position: Q2 2025 in Review

Group One Trading sold out of Oramed Pharmaceuticals (ORMP) in Q2 2025, closing a stake of 3,310 shares — an estimated $7.3K sold.

Group One Trading first reported a position in ORMP in Q1 2014 and held it in 29 quarters. The position peaked at $1.23M in Q4 2022. 47 funds tracked by Wall St. Rank hold ORMP as of Q2 2025.

Group One Trading reported no remaining Oramed Pharmaceuticals position as of Q2 2025 after selling out during the quarter.
Group One Trading sold 3,310 Oramed Pharmaceuticals shares in Q2 2025, an estimated $7.3K.
Group One Trading first reported a position in Oramed Pharmaceuticals in Q1 2014 and held it in 29 quarters.
Group One Trading's Oramed Pharmaceuticals position peaked at $1.23M in Q4 2022.
47 funds tracked by Wall St. Rank held Oramed Pharmaceuticals as of Q2 2025.

Based on Group One Trading's 13F filing for Q2 2025, filed 14 Aug 2025.